Activest Wealth Management’s 10x Genomics TXG Stock Holding History

Activest Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268	Buy	+7	New	+$183	﹤0.01%	1135
2025 Q4	–	Sell	-7	Closed	-$82	–	1304
2025 Q3	$82	Hold	7	–	–	﹤0.01%	1070
2025 Q2	$81	Sell	7 -134	-95%	-$1.22K	﹤0.01%	982
2025 Q1	$1.23K	Buy	141 +100	+244%	+$1.26K	﹤0.01%	741
2024 Q4	$589	Hold	41	–	–	﹤0.01%	514
2024 Q3	$926	Hold	41	–	–	﹤0.01%	461
2024 Q2	$797	Hold	41	–	–	﹤0.01%	445
2024 Q1	$1.54K	Hold	41	–	–	﹤0.01%	318
2023 Q4	$2.29K	Hold	41	–	–	﹤0.01%	266
2023 Q3	$1.69K	Hold	41	–	–	﹤0.01%	279
2023 Q2	$7.47K	Hold	41	–	–	0.01%	195
2023 Q1	$2.13K	Hold	41	–	–	﹤0.01%	252
2022 Q4	$1.49K	Hold	41	–	–	﹤0.01%	413
2022 Q3	$1K	Hold	41	–	–	﹤0.01%	422
2022 Q2	$2K	Hold	41	–	–	﹤0.01%	341
2022 Q1	$3K	Hold	41	–	–	﹤0.01%	287
2021 Q4	$6K	Hold	41	–	–	﹤0.01%	247
2021 Q3	$6K	Buy	+41	New	+$7.04K	﹤0.01%	276

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Activest Wealth Management's TXG Position: Q2 2026 in Review

Activest Wealth Management opened a new position in 10x Genomics (TXG) in Q2 2026: 7 shares worth $268. The stake represents ﹤0.01% of the portfolio and ranks #1135 among its holdings. This is a return to the name: Activest Wealth Management previously reported a position in TXG as recently as Q3 2025.

Activest Wealth Management first reported a position in TXG in Q3 2021 and has held it in 18 quarters since. The position peaked at $7.47K in Q2 2023. 76 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Activest Wealth Management held 7 shares of 10x Genomics worth $268 as of Q2 2026.
10x Genomics was a new Activest Wealth Management position in Q2 2026.
10x Genomics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1135 holding.
Activest Wealth Management first reported a position in 10x Genomics in Q3 2021 and has held it in 18 quarters since.
Activest Wealth Management's 10x Genomics position peaked at $7.47K in Q2 2023.
76 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.